The new kid on the block: suicide gene therapy to modulate cancer immunosurveillance for children with high-risk malignant brain tumors
Neuro Oncol
.
2019 Mar 18;21(4):419-420.
doi: 10.1093/neuonc/noz026.
Authors
Sameer F Sait
1
,
Matthias A Karajannis
1
Affiliation
1
Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.
PMID:
30852609
PMCID:
PMC6422432
DOI:
10.1093/neuonc/noz026
No abstract available
Publication types
Comment
MeSH terms
Brain Neoplasms*
Child
Ependymoma*
Genetic Therapy
Glioma*
Humans
Immunotherapy
Monitoring, Immunologic
Grants and funding
K12 CA184746/CA/NCI NIH HHS/United States
P30 CA008748/CA/NCI NIH HHS/United States